|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.85 NGN | 0.00% |
|
0.00% | -4.64% |
Neimeth International Pharmaceuticals Plc reported earnings results for the full year ended September 30, 2022. For the full year, the company reported sales was NGN 2,702.85 million compared to NGN 3,046.66 million a year ago. Net loss was NGN 109.66 million compared to net income of NGN 270.58 million a year ago.
Basic loss per share from continuing operations was NGN 0.0577 compared to basic earnings per share from continuing operations of NGN 0.14 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.64% | 5.18M | |
| +32.36% | 694B | |
| +30.01% | 593B | |
| -1.60% | 371B | |
| +20.07% | 331B | |
| +6.04% | 290B | |
| +14.49% | 239B | |
| -3.31% | 209B | |
| +10.07% | 209B | |
| +9.27% | 169B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 